Agneta Tjernberg

Agneta Tjernberg is a highly experienced principal scientist currently working at Oncopeptides AB since March 2023. Previous roles include project leader and coordinator in bioanalysis and chemical and pharmaceutical toxicology at RISE Research Institutes of Sweden, and director of bioanalysis and translational sciences at Sobi - Swedish Orphan Biovitrum AB. Agneta has a robust background in drug design and development, specializing in glycoprotein characterization and protein quantification, with extensive expertise in liquid chromatography-mass spectrometry and immunoassay methods. Prior positions encompass senior scientist roles at Swedish Orphan Biovitrum, iNovacia AB, Biovitrum AB, and Pharmacia Corporation, as well as research positions at the Rockefeller University and KabiVitrum. Agneta holds a PhD in Medical Biochemistry and Biophysics from Karolinska Institutet and a BSc in Analytical Chemistry from Stockholm University.